Form 4: Hubbell CFO Granted Restricted Stock, Stock Appreciation Rights
Insider Transaction Report
Hubbell's CFO, Joseph A. Capozzoli, received a grant of 531 restricted common shares and 2,169 stock appreciation rights.
Summary
- Joseph A. Capozzoli, Senior Vice President and CFO of Hubbell Inc. (HUBB), was granted 531 shares of common stock.
- These 531 restricted common shares were granted at a price of $0 and will vest on February 17, 2029, which is the third anniversary of the grant date.
- Following this transaction, Mr. Capozzoli directly beneficially owns 6,396 shares of common stock.
- Mr. Capozzoli also received a grant of 2,169 Stock Appreciation Rights (SARs) with an exercise price of $517.58.
- These SARs were granted at a price of $0 and will vest and become exercisable in three equal annual installments, beginning on February 17, 2027.
- The Stock Appreciation Rights have an expiration date of February 17, 2036.
- Following this transaction, Mr. Capozzoli directly beneficially owns 2,169 Stock Appreciation Rights.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, as it represents routine executive compensation that aligns management's interests with long-term shareholder value. It is not a significant market-moving event but reflects standard corporate governance practices.
Positives
- The grant of restricted stock and stock appreciation rights aligns the financial interests of the CFO with those of the shareholders, incentivizing long-term company performance.
- Equity compensation is a standard component of executive remuneration, indicating a structured approach to management incentives.
Future Outlook
The filing does not contain forward-looking statements or guidance beyond the vesting schedules of the granted equity awards.
Industry Context
StockSavvy.ai notes that equity grants, such as restricted stock and stock appreciation rights, are a common and widely accepted form of executive compensation across various industries. These grants are designed to tie executive performance to shareholder value creation over the long term.
Comparison to Industry Standards
- Equity-based compensation, including restricted stock and SARs, is a standard practice for executive remuneration in publicly traded companies, aligning management incentives with shareholder interests.
- The specific number of shares and SARs granted to Joseph A. Capozzoli is consistent with typical compensation packages for CFOs at companies of Hubbell's size and market capitalization, though direct comparisons would require detailed peer group analysis.
Stakeholder Impact
- Shareholders: The equity grants are intended to align the CFO's long-term interests with shareholder value creation, potentially leading to improved company performance.
- Employees: No direct impact on general employees is indicated by this filing, though executive compensation practices can indirectly influence overall compensation philosophy.
Next Steps
- The restricted common stock will vest on February 17, 2029.
- The Stock Appreciation Rights will begin vesting in three equal annual installments starting February 17, 2027.
Key Dates
| Date | Description |
|---|---|
| 02/17/2026 | Date of grant for restricted common stock and stock appreciation rights. |
| 02/17/2027 | First annual installment vesting date for Stock Appreciation Rights. |
| 02/17/2029 | Vesting date for the 531 restricted common shares. |
| 02/19/2026 | Date the Form 4 was signed and filed. |
| 02/17/2036 | Expiration date for the Stock Appreciation Rights. |
Keywords
HUBB, Hubbell, Form 4, Insider Transaction, Restricted Stock, Stock Appreciation Rights, SARs, Executive Compensation, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.